Preferred Partner Agreement

Preferred Partner Agreement

Venn Life Sciences (part of Open Orphan Plc), a European-focussed, rare and orphan drug consulting services platform company, is pleased to announce the signing of a preferred partner agreement with Ipsen Group. The agreement selects Venn Life Sciences which is part of the Open Orphan group, as a preferred partner for Ipsen’s Data Management and Biostatistics. The preferred vendor structure will last for a 3-year period. This partnership has already delivered substantial revenues for the Open Orphan group and positions the business as an integrated drug development partner for Biopharma